Takeda’s Qdenga nears approval in EU, and beyond, thanks to special regulatory pathway zbecker Fri, 10/14/2022 – 11:17 More: Takeda's Qdenga nears approval in EU, and beyond, thanks to special regulatory pathway Source: fierce
read moreAtara on verge of landmark approval for first allogeneic T-cell therapy kdunleavy Fri, 10/14/2022 – 10:43 More: Atara on verge of landmark approval for first allogeneic T-cell therapy Source: fierce
read moreFlying glass fears force Exela to recall 49 lots of metabolic acidosis injection fkansteiner Fri, 10/14/2022 – 10:30 More: Flying glass fears force Exela to recall 49 lots of metabolic acidosis injection Source: fierce
read moreNovartis’ blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal fkansteiner Fri, 10/14/2022 – 09:23 More: Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal Source: fierce
read moreTherapy involves patients with colorectal cancer at 20 medical centres More: XBiotech enrols first patient in Natrunix study Source: News
read moreResearch has demonstrated a strong safety prolife and reduced tics among participants More: Patient recruitment completed in Tourette syndrome study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals